Paid Clinical Trials in Torrance, CA
As of August 2026, 159 paid clinical trials are recruiting in Torrance, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Torrance offers studies at sites including Torrance Memorial Physician Network - Cancer Care for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Stage IV Lung Cancer AJCC v8, Coronary Artery Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Torrance
Trials by drug in Torrance
Filter results
Newly added in Torrance
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
149 clinical trials
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
A Study of Brenipatide in Adult Participants With Schizophrenia
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
SELUTION 4 De Novo Small Vessel IDE Trial
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Top Research Study Locations in Torrance
Researchers run research studies in Torrance, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Torrance Memorial Physician Network - Cancer Care | Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | 20 |
| City of Hope South Bay | Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain | 17 |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Atherosclerosis, C. Diff Infection, C.Difficile Diarrhea | 8 |
| Harbor-UCLA Medical Center | Diabetes Mellitus, Type 1, End-Stage Renal Disease, Heart Failure | 5 |
| Neurocrine Clinical Site | Schizophrenia, Tardive Dyskinesia | 4 |
| Torrance Memorial Medical Center | AMI Cardiogenic Shock, Aortic Stenosis, Coronary Artery Disease | 4 |
| Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center | Acute Myocardial Infarction, Diabetes Mellitus, Type 2, Heart Failure | 4 |
| Collaborative Neuroscience Research, LLC | Bipolar Disorder Type I With Mania, Bipolar Disorder Type I With Mania or Mania With Mixed Features, Schizophrenia | 3 |
| Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center | Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities, Moderate Aortic Valve Stenosis, Peripheral Arterial Disease | 3 |
| The Lundquist Institute | ASCVD, ASCVD Management, Atherosclerosis Cardiovascular Disease | 3 |
| The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 3 |
| Breathe Clear Institute | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Chronic Rhinosinusitis Without Nasal Polyps | 2 |
| CS Cancer at the Hunt Cancer Center | Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Breast Cancer, Carcinoma | 2 |
| City of Hope at South Bay | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
| GSK Investigational Site | Multiple Myeloma, Neoplasms, Head and Neck | 2 |
| Harbor UCLA Medical Center | Hypertension, Ketamine Infusion, Myocardial Infarction | 2 |
| Hunt Cancer Institute, an Affiliate of CS Cancer | Early Stage Triple-Negative Breast Carcinoma, TNBC, TNBC - Triple-Negative Breast Cancer | 2 |
| Lundquist Inst BioMed at Harbor | Chronic Myelogenous Leukemia - Chronic Phase, Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors | 2 |
| Macula Retina Vitreous Research Institute | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA), Neovascular Age-related Macular Degeneration | 2 |
| Retina Macula Institute | Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, Macular Degeneration | 2 |
| The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Cente | B-Cell Non-Hodgkins Lymphoma, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | 2 |
| Torrance Memorial Physicians Network | Colorectal Neoplasms | 2 |
| UCLA Hematology/Oncology - Torrance | Cancer of the Prostate, Hormone Sensitive Prostate Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC) | 2 |
| Genesis Research LLC | Non-muscle Invasive Bladder Cancer, Carcinoma in Situ, Non-Muscle Invasive Bladder Neoplasms | 2 |
Active & Upcoming Studies in Torrance (2026)
Recruiting trials in Torrance grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (54 active studies)
- Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer · Phase 2 · Yuan Yuan
- A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression · Phase 3 · K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Cardiovascular (14 active studies)
- A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis · Phase 2 · Beijing Inno Medicine Co., Ltd.
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure · Boston Scientific Corporation
Neurology & pain (10 active studies)
- Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults · Phase 2 · Mohsen Saidinejad
- A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis · Phase 3 · Zenas BioPharma (USA), LLC
Mental health & behavior (8 active studies)
- A Study of Brenipatide in Adult Participants With Schizophrenia · Phase 2 · Eli Lilly and Company
- Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. · Phase 2 · LB Pharmaceuticals Inc.
Eye & vision (6 active studies)
- An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease · Phase 2 · Dompé Farmaceutici S.p.A
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
Diabetes & metabolic (5 active studies)
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
- Starting Technology in At Risk Type 1 Diabetes Study · University of California, Los Angeles
HIV / STI (2 active studies)
- Menopausal HT for Women Living With HIV (HoT) · Phase 4 · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission · Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)
Vaccines (1 active study)
Common conditions studied in Torrance
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies)
- Breast Cancer (5 active studies)
- Stage IV Lung Cancer AJCC v8 (5 active studies)
- Coronary Artery Disease (4 active studies)
- Early Stage Triple-Negative Breast Carcinoma (4 active studies)
- Schizophrenia (4 active studies)
Leading research sponsors in Torrance
- SWOG Cancer Research Network
- NRG Oncology
- National Cancer Institute (NCI)
- AstraZeneca
- City of Hope Medical Center
Frequently asked questions
How many paid clinical trials are currently recruiting in Torrance?
There are approximately 159 recruiting clinical trials in Torrance, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Torrance pay participants?
Most recruiting trials in Torrance compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Torrance?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Torrance?
The most common conditions under active study in Torrance include Anatomic Stage II Breast Cancer AJCC v8 (5), Breast Cancer (5), Stage IV Lung Cancer AJCC v8 (5), Coronary Artery Disease (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Torrance?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Torrance on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Torrance?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Torrance?
Recruiting research sites in Torrance include Torrance Memorial Physician Network - Cancer Care, City of Hope South Bay, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Torrance right now?
The largest active categories in Torrance are Cancer & tumors (54), Cardiovascular (14), Neurology & pain (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.